UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection

Cancer science, 2019-08, Vol.110 (8), p.2573-2589

2019

Volltextzugriff (PDF)

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis

International journal of molecular sciences, 2017-02, Vol.18 (2), p.470

2017

Volltextzugriff (PDF)

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy

Urologic oncology, 2017-05, Vol.35 (5), p.183-191

2017

Volltextzugriff (PDF)

GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model

Urologic oncology, 2014-11, Vol.32 (8), p.1126-1134

2014

Volltextzugriff (PDF)

Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?

Therapeutic Advances in Urology, 2016-04, Vol.8 (2), p.118-129

2016

Volltextzugriff (PDF)

Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms

Urologic oncology, 2015-11, Vol.33 (11), p.464-475

2015

Volltextzugriff (PDF)

The contemporary role of lymph node dissection in the management of renal cell carcinoma

Therapeutic Advances in Urology, 2018-11, Vol.10 (11), p.335-342

2018

Volltextzugriff (PDF)

Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor

The Journal of biological chemistry, 2017-12, Vol.292 (51), p.21180-21192

2017

Volltextzugriff (PDF)

Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome

The Journal of urology, 2006-09, Vol.176 (3), p.979-984

2006

Volltextzugriff (PDF)

Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease

The Journal of urology, 2019-12, Vol.202 (6), p.1199-1208

2019

Volltextzugriff (PDF)

Population Based Survival Data on Urachal Tumors

The Journal of urology, 2006-06, Vol.175 (6), p.2042-2047

2006

Volltextzugriff (PDF)

Photodynamic Therapy for Urological Malignancies: Past to Current Approaches

The Journal of urology, 2006-04, Vol.175 (4), p.1201-1207

2006

Volltextzugriff (PDF)

Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation

Oncology reports, 2015-10, Vol.34 (4), p.1968-1976

2015

Volltextzugriff (PDF)

Endoplasmic reticulum protein ERp46 in renal cell carcinoma

PloS one, 2014-03, Vol.9 (3), p.e90389-e90389

2014

Volltextzugriff (PDF)

Androgen Induces Adaptation to Oxidative Stress in Prostate Cancer: Implications for Treatment with Radiation Therapy

Neoplasia (New York, N.Y.), 2007-01, Vol.9 (1), p.68-80

2007

Volltextzugriff (PDF)

Uncovering the Metabolic Complications of Androgen Deprivation Therapy in Patients with Prostate Cancer—Where Do We Take it Next?

The Journal of urology, 2015-06, Vol.193 (6), p.1882-1883

Pinthus, Jehonathan H

2015

Volltextzugriff (PDF)

Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy

Urologic oncology, 2014-10, Vol.32 (7), p.975-980

2014

Volltextzugriff (PDF)

Single‐session primary high‐intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation‐based technology

BJU international, 2012-10, Vol.110 (8), p.1142-1148

2012

Volltextzugriff (PDF)

Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations

Expert review of anticancer therapy, 2009-07, Vol.9 (7), p.975-987

2009

Volltextzugriff (PDF)

Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications

Canadian Urological Association journal, 2011-08, Vol.5 (4), p.274-282

2011

Volltextzugriff (PDF)

Cardiovascular risk in ADT recipients: does the type of ADT matter?

Prostate cancer and prostatic diseases, 2024-09, Vol.27 (3), p.435-437

2024

Volltextzugriff (PDF)

Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect

Molecular cancer therapeutics, 2007-02, Vol.6 (2), p.570-577

2007

Volltextzugriff (PDF)

Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist

Prostate cancer and prostatic diseases, 2021-03, Vol.24 (1), p.177-185

2021

Volltextzugriff (PDF)

What can surrogate tissues tell us about the oxidative stress status of the prostate? A hypothesis-generating in-vivo study

PloS one, 2010-12, Vol.5 (12), p.e15880-e15880

2010

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(135)
Buchkapitel
(1)

Sprache

Englisch
(134)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy

GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model

Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?

Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms

The contemporary role of lymph node dissection in the management of renal cell carcinoma

Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor

Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome

Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease

Population Based Survival Data on Urachal Tumors

Photodynamic Therapy for Urological Malignancies: Past to Current Approaches

Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation

Endoplasmic reticulum protein ERp46 in renal cell carcinoma

Androgen Induces Adaptation to Oxidative Stress in Prostate Cancer: Implications for Treatment with Radiation Therapy

Uncovering the Metabolic Complications of Androgen Deprivation Therapy in Patients with Prostate Cancer—Where Do We Take it Next?

Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy

Single‐session primary high‐intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation‐based technology

Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations

Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications

Cardiovascular risk in ADT recipients: does the type of ADT matter?

Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect

Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist

Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance

What can surrogate tissues tell us about the oxidative stress status of the prostate? A hypothesis-generating in-vivo study

Suchergebnisse filtern